INIS
patients
100%
humans
65%
comparative evaluations
45%
reviews
44%
proteins
44%
drugs
44%
levels
40%
diseases
36%
evaluation
36%
data
36%
receptors
35%
risks
35%
anticoagulants
32%
cancer
31%
plasma
30%
genes
30%
inflammation
28%
in vitro
27%
assessments
26%
concentration
25%
rats
25%
performance
24%
laboratories
24%
thrombin
23%
control
22%
mice
21%
inhibition
21%
antibodies
20%
synthesis
20%
doses
19%
values
19%
sleep
18%
covid-19
18%
sensitivity
17%
brain
17%
in vivo
16%
populations
16%
design
16%
chains
16%
liver
16%
molecules
15%
interactions
15%
tissues
15%
heparin
15%
toxicity
14%
kinases
14%
lysosomes
14%
testing
14%
tumors
13%
enzymes
13%
applications
13%
injuries
13%
range
12%
kidneys
12%
lipids
12%
membranes
12%
therapy
12%
tools
11%
interventions
11%
polymers
11%
vaccines
11%
distribution
11%
detection
11%
monitoring
11%
messenger-rna
11%
nanoparticles
11%
blood
10%
indoles
10%
coronaviruses
10%
epidermis
10%
women
10%
thrombosis
10%
spectra
10%
administration
10%
adults
10%
surfaces
10%
production
10%
screening
10%
regulations
10%
losses
9%
information
9%
oxidation
9%
biological markers
9%
investigations
9%
mitochondria
9%
symptoms
9%
aggregation
9%
apoptosis
8%
reagents
8%
stability
8%
density
8%
motors
8%
learning
8%
skin
8%
muscles
8%
safety
8%
growth
8%
substrates
8%
mutations
8%
injection
8%